Trials / Unknown
UnknownNCT05760560
Incidence of Postoperative Residual Neuromuscular Blockade in the Era of Sugammadex
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 52 (estimated)
- Sponsor
- Seoul National University Hospital · Academic / Other
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
This study is a prospective observational study. A total 52 patients will be included in this study. We will observe the incidence of postoperative residual neuromuscular blockade in patients receiving sugammadex.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sugammadex | At the end of surgery, neuromucular blockade will be reversed with 2mg/kg or 4mg/kg sugammadex depending on the depth of neuromuscular blockade. |
Timeline
- Start date
- 2023-03-15
- Primary completion
- 2023-08-31
- Completion
- 2024-08-31
- First posted
- 2023-03-08
- Last updated
- 2023-04-14
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT05760560. Inclusion in this directory is not an endorsement.